CompletedNot Applicable

Prospective Cohort Study of Association of Insulin Resistance/Steatosis With Hepatic Fibrosis in CHB and NAFLD

South Korea500 participantsStarted 2013-01

Plain-language summary

Hepatic steatosis and insulin resistance are associated with severity of fibrosis in non-alcoholic fatty liver disease (NAFLD) and chronic hepatitis C. However, clinical significance of steatosis and insulin resistance on fibrosis in chronic hepatitis B (CHB) is not well established. The aim was to investigate the relationship between insulin resistance, hepatic steatosis, and fibrosis in patients with CHB.

Who can participate

Age range20 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Chronic hepatitis B patients * With evidences of hepatic steatosis on ultrasonography or pathology Exclusion Criteria: * significant alcohol consumption or other known liver diseases

What they're measuring

Insulin resistance and fibrosis indices

Timeframe: one year

Trial details

NCT IDNCT02031913

SponsorSeoul National University Boramae Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-11

View on ClinicalTrials.gov More Chronic Hepatitis B trials